Regenerative Medical Technology (RMTG) Preferred Shares (2017 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Preferred Shares of $1.0 for Q1 2026, down 99.9% year-over-year from $1050.0 in Q1 2025, and down 99.9% quarter-over-quarter from $1050.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Preferred Shares (2017 - 2026) Analysis & Trends
Regenerative Medical Technology's Preferred Shares history runs 10 years deep, the most recent figure standing at $1.0 for Q1 2026.
- In Q1 2026, Preferred Shares fell 99.9% year-over-year to $1.0; the TTM figure through Mar 2026 stood at $1.0 (down 99.9% YoY), while the FY2025 annual figure was $1050.0, changed 0.0% from the prior year.
- Preferred Shares for Q1 2026 stood at $1.0, down from $1050.0 in the prior quarter.
- The five-year high for Preferred Shares was $5.0 million in Q2 2023, with the low at $1.0 in Q1 2026.
- The 5-year median for Preferred Shares is $1050.0 (2023), against an average of $353521.4.
- The sharpest annual moves came in 2023 and 2024: Preferred Shares soared 50385660.0% in 2023, then tumbled 99.98% in 2024.
- Regenerative Medical Technology's Preferred Shares stood at $10.0 in 2022, then changed by 0.0% to $10.0 in 2023, then jumped by 10400.0% to $1050.0 in 2024, then changed by 0.0% to $1050.0 in 2025, then sank by 99.9% to $1.0 in 2026.
- Business Quant data shows RMTG's Preferred Shares at $1.0 in Q1 2026, $1050.0 in Q4 2025, and $1050.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 1,050.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 |
| Dec 31, 2025 | 1,050.00 |
| Sep 30, 2025 | 1,050.00 |
| Jun 30, 2025 | 10.00 |
| Mar 31, 2025 | 1,050.00 |
| Dec 31, 2024 | 1,050.00 |
| Sep 30, 2024 | 1,050.00 |
| Jun 30, 2024 | 1,050.00 |
| Mar 31, 2024 | 963,866.00 |
| Dec 31, 2023 | 10.00 |
| Sep 30, 2023 | 10.00 |
| Jun 30, 2023 | 5.04 Mn |
| Mar 31, 2023 | 1,050.00 |
| Dec 31, 2022 | 10.00 |
| Sep 30, 2022 | 10.00 |
| Jun 30, 2022 | 10.00 |
| Mar 31, 2022 | 10.00 |
| Dec 31, 2021 | 1,050.00 |
| Sep 30, 2021 | 10.00 |
| Jun 30, 2021 | 50.00 |